Biomarin Pharmaceutical Inc (BMRN) Insider Trading
- $1,316,196.75
- $342,139,664.94
- Nov. 12, 2024
- Jean Jacques Bienaime
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 4, 2022 | CFO | 11,800 | $84.50 | Sell | $997,100.00 | |
May 2, 2022 | EVP | 15,347 | $80.38 | Sell | $1,233,591.86 | |
May 2, 2022 | Director | 3,878 | $82.09 | Sell | $318,345.02 | |
April 28, 2022 | CEO | 20,000 | $83.79 | Sell | $1,675,800.00 | |
April 18, 2022 | CEO | 20,000 | $81.91 | Sell | $1,638,200.00 | |
April 14, 2022 | Director | 4,250 | $83.66 | Sell | $355,555.00 | |
April 14, 2022 | CEO | 10,000 | $83.66 | Sell | $836,600.00 | |
April 13, 2022 | EVP | 1,180 | $82.47 | Sell | $97,314.60 | |
March 29, 2022 | EVP | 1,618 | $79.43 | Sell | $128,517.74 | |
March 23, 2022 | EVP | 6,129 | $81.78 | Sell | $501,229.62 | |
March 21, 2022 | EVP | 6,129 | $81.29 | Sell | $498,226.41 | |
March 10, 2022 | CEO | 15,000 | $77.57 | Sell | $1,163,550.00 | |
Feb. 28, 2022 | Director | 6,396 | $78.33 | Sell | $500,998.68 | |
Jan. 14, 2022 | Director | 4,250 | $87.61 | Sell | $372,342.50 | |
Jan. 13, 2022 | CEO | 5,000 | $87.86 | Sell | $439,300.00 | |
Dec. 15, 2021 | CEO | 6,000 | $82.71 | Sell | $496,260.00 | |
Dec. 1, 2021 | CEO | 1,500 | $87.22 | Sell | $130,830.00 | |
Oct. 26, 2021 | EVP | 2,739 | $73.60 | Sell | $201,590.40 | |
May 10, 2021 | CEO | 8,513 | $77.29 | Sell | $657,969.77 | |
May 7, 2021 | CFO | 6,709 | $79.50 | Sell | $533,365.50 | |
May 7, 2021 | CEO | 25,000 | $78.12 | Sell | $1,953,000.00 | |
May 6, 2021 | Director | 5,068 | $78.38 | Sell | $397,229.84 | |
May 3, 2021 | EVP | 4,673 | $78.30 | Sell | $365,895.90 | |
April 23, 2021 | CEO | 10,000 | $79.34 | Sell | $793,400.00 | |
April 19, 2021 | EVP | 2,709 | $79.58 | Sell | $215,582.22 | |
April 8, 2021 | EVP | 1,537 | $78.81 | Sell | $121,130.97 | |
April 1, 2021 | CFO | 5,692 | $76.30 | Sell | $434,299.60 | |
March 24, 2021 | EVP | 1,181 | $76.30 | Sell | $90,110.30 | |
March 18, 2021 | EVP | 1,308 | $77.99 | Sell | $102,010.92 | |
March 11, 2021 | CEO | 7,000 | $77.68 | Sell | $543,760.00 | |
March 5, 2021 | Director | 5,000 | $76.28 | Sell | $381,400.00 | |
Feb. 19, 2021 | CEO | 7,000 | $83.58 | Sell | $585,060.00 | |
Feb. 17, 2021 | CEO | 8,000 | $84.54 | Sell | $676,320.00 | |
Jan. 29, 2021 | CEO | 8,334 | $82.67 | Sell | $688,971.78 | |
Jan. 27, 2021 | CEO | 8,333 | $85.49 | Sell | $712,388.17 | |
Dec. 28, 2020 | CEO | 1,500 | $88.77 | Sell | $133,155.00 | |
Oct. 14, 2020 | EVP | 2,121 | $79.91 | Sell | $169,489.11 | |
Aug. 31, 2020 | Director | 12,800 | $78.26 | Buy | $1,001,728.00 | |
Aug. 3, 2020 | Director | 2,500 | $120.35 | Sell | $300,875.00 | |
July 20, 2020 | Insider | 126,389 | $130.00 | Sell | $16,430,570.00 | |
July 13, 2020 | Insider | 23,011 | $130.00 | Sell | $2,991,430.00 | |
June 26, 2020 | Director | 4,430 | $123.61 | Sell | $547,592.30 | |
June 19, 2020 | EVP | 15,000 | $124.00 | Sell | $1,860,000.00 | |
June 5, 2020 | Director | 4,430 | $107.46 | Sell | $476,047.80 | |
May 8, 2020 | CEO | 20,000 | $91.72 | Sell | $1,834,400.00 | |
May 4, 2020 | CEO | 5,000 | $88.00 | Sell | $440,000.00 | |
May 1, 2020 | EVP | 12,504 | $89.38 | Sell | $1,117,607.52 | |
May 1, 2020 | CEO | 4,000 | $89.38 | Sell | $357,520.00 | |
April 28, 2020 | CEO | 20,000 | $97.58 | Sell | $1,951,600.00 | |
April 24, 2020 | Insider | 20,000 | $95.88 | Sell | $1,917,600.00 |
Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.
The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere
The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.
Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.
David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.
The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.
The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.
The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.